Other newcomers included Delhi-based brothers Ramesh Kumar and Mukand Lal Dua of Relaxo Footwears, which owns affordable footwear brands; dairyman, R G Chandramogan of Hatsun Agro; Premchand Godha, who chairs IPCA Laboratories, manufacturing formulations, bulk drugs and drug intermediates; G Rajendran, founder of jewellery chain, GRT Jewellers.
Half of the nation’s 100 richest saw gains, rising a collective 14 per cent to $517.5 billion even as the benchmark Sensex remained flat from a year ago, said Forbes.
More than half of the increase can be ascribed to one individual: Mukesh Ambani
at No. 1 for the 13th year, who added $37.3 billion to his fortune — a rise of 73 per cent — to a net worth of $88.7 billion, it added.
Gautam Adani retained his No. 2 spot, as his net worth was boosted 61 per cent to $25.2 billion while tech tycoon, Shiv Nadar jumped three places to No. 3 with $20.4 billion.
Vaccine maker, Cyrus Poonawalla, whose Serum Institute has joined the race to produce Covid-19 vaccines, entered the Top-10.
The impact of the pandemic showed up on the list as all pharmaceutical billionaires on the list saw their wealth rise. Biocon’s Kiran Mazumdar-Shaw became the highest wealth gainer in percentage terms, said Forbes. Biocon is set to start phase 4 trials of a potential Covid-19 drug.
Despite the pandemic, fewer billionaires saw their wealth erode this year than they did in 2019 and about and more than a third of the listees saw their wealth decline, notably those with interests in real estate.